Guanlin Wang
Papers
1
Total Citations
5
H-Index
1
About
Guanlin Wang is a leading researcher in advanced drug delivery systems, with a primary focus on microneedle technology for overcoming biological barriers. His most-cited work, "Microneedle Technology for Overcoming Biological Barriers: Advancing Biomacromolecular Delivery and Therapeutic Applications in Major Diseases" (2025, 5 citations), addresses a critical challenge in modern medicine: the effective administration of biomacromolecules—such as proteins, peptides, and nucleic acids—for treating major diseases including tumors, infections, cardiovascular conditions, metabolic disorders, and autoimmune diseases. Wang’s major contribution lies in designing and characterizing microneedle platforms that enable minimally invasive, patient-friendly delivery of these therapeutics, bypassing traditional limitations like enzymatic degradation and poor permeability. His research bridges the gap between laboratory innovation and clinical translation, offering promising solutions for diseases that currently rely on professional administration. With a growing citation impact, Wang’s work is shaping the future of transdermal and intradermal drug delivery, making him a notable figure in biomaterials and pharmaceutical engineering.
Research Focus
Key Achievements
Top Papers
- 1